PatientsVille.com Logo

PatientsVille

Eskazole Side Effects

Common Eskazole Side Effects


The most commonly reported Eskazole side effects (click to view or check a box to report):

White Blood Cell Count Decreased (6)
Hepatic Enzyme Increased (5)
Hip Dysplasia (4)
Alopecia (4)
Gamma-glutamyltransferase Increased (3)
Aspartate Aminotransferase Increased (3)
Arrhythmia (3)
Alanine Aminotransferase Increased (3)
Hepatitis (3)
Leukopenia (3)
Transaminases Increased (3)
Pancytopenia (3)
Palpitations (3)
Osteoarthritis (3)
Liver Abscess (2)
Hepatitis Toxic (2)
Liver Disorder (2)
Supraventricular Tachycardia (2)
Pruritus (2)
Neutrophil Count Decreased (2)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Eskazole Side Effects Reported to FDA

The following Eskazole reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Eskazole on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Blood Immunoglobulin E Increased, Computerised Tomogram Thorax Abnormal, Eosinophil Count Increased, Rash, Pruritus, Liver Disorder, Malaise, Hepatic Enzyme Increased
This is a report of a 36-year-old male patient (weight: NA) from JAPAN, suffering from the following symptoms/conditions: toxocariasis, who was treated with Eskazole (dosage: 1000mg Per Day, start time: Sep 14, 2009), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Blood Immunoglobulin E Increased
  • Computerised Tomogram Thorax Abnormal
  • Eosinophil Count Increased
  • Rash
  • Pruritus
  • Liver Disorder
  • Malaise
  • Hepatic Enzyme Increased
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Eskazole treatment in male patients, resulting in blood immunoglobulin e increased side effect.

Disseminated Intravascular Coagulation, Leukopenia, Liver Abscess, Multi-organ Failure, Pyrexia, White Blood Cell Count Decreased
This report suggests a potential Eskazole Disseminated Intravascular Coagulation, Leukopenia, Liver Abscess, Multi-organ Failure, Pyrexia, White Blood Cell Count Decreased side effect(s) that can have serious consequences. A 73-year-old male patient (weight: NA) from JAPAN was diagnosed with the following symptoms/conditions: NA and used Eskazole (dosage: 600mg Per Day) starting NS. Soon after starting Eskazole the patient began experiencing various side effects, including:
  • Disseminated Intravascular Coagulation
  • Leukopenia
  • Liver Abscess
  • Multi-organ Failure
  • Pyrexia
  • White Blood Cell Count Decreased
Drugs used concurrently: NA.The patient was hospitalized. Although Eskazole demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as disseminated intravascular coagulation, may still occur.

Transaminases Increased
This Transaminases Increased problem was reported by a consumer or non-health professional from JAPAN. A 42-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: toxocariasis. On NS this consumer started treatment with Eskazole (dosage: NA). The following drugs were being taken at the same time: NA. When commencing Eskazole, the patient experienced the following unwanted symptoms/side effects:
  • Transaminases Increased
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as transaminases increased, may become evident only after a product is in use by the general population.

Polyneuropathy
This is a report of a 60-year-old male patient (weight: NA) from GERMANY. The patient developed the following symptoms/conditions: NA and was treated with Eskazole (dosage: NA) starting NS. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
  • Polyneuropathy
This opens a possibility that Eskazole treatment could cause the above reactions, including death, and some male subjects may be more susceptible.


Acute Hepatic Failure, Alopecia, Bile Duct Obstruction, Ultrasound Scan Abnormal
A female patient (weight: NA) from SPAIN with the following symptoms/conditions: hepatic echinococciasis started Eskazole treatment (dosage: NA) on Aug 20, 2009. Soon after starting Eskazole treatment, the subject experienced various side effects, including:
  • Acute Hepatic Failure
  • Alopecia
  • Bile Duct Obstruction
  • Ultrasound Scan Abnormal
Concurrently used drugs: NA. This finding indicates that some female patients could be more vulnerable to Eskazole.

Acute Hepatic Failure, Alopecia
A 58-year-old female patient from SPAIN (weight: NA) experienced symptoms, such as: NA and was treated with Eskazole(dosage: NA). The treatment was initiated on Aug 20, 2009. After that a consumer reported the following side effect(s):
  • Acute Hepatic Failure
  • Alopecia
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Eskazole efficacy: NA.

Pancytopenia
In this report, Eskazole was administered for the following condition: NA.A 78-year-old female consumer from SPAIN (weight: NA) started Eskazole treatment (dosage: NA) on Mar 02, 2009.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Pancytopenia
A possible interaction with other drugs could have contributed to this reaction: NA.The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Eskazole treatment could be related to the listed above side effect(s).

Erythema Multiforme, Leukopenia, Neutropenia, Toxic Skin Eruption
This is a report of the following Eskazole side effect(s):
  • Erythema Multiforme
  • Leukopenia
  • Neutropenia
  • Toxic Skin Eruption
A 71-year-old male patient from FRANCE (weight: NA) presented with the following condition: pulmonary echinococciasis and received a treatment with Eskazole (dosage: 100mg Twice Per Day) starting: Jun 01, 2008.The following concurrently used drugs could have generated interactions: NA.This report suggests that a Eskazole treatment could be associated with the listed above side effect(s).

Liver Abscess, White Blood Cell Count Decreased
This Eskazole report was submitted by a 73-year-old male consumer from JAPAN (weight: NA). The patient was diagnosed with: NA and Eskazole was administered (dosage: NA) starting: NS. The consumer developed a set of symptoms:
  • Liver Abscess
  • White Blood Cell Count Decreased
Other drugs used simultaneously: NA.Those unexpected symptoms could be linked to a Eskazole treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Liver Disorder
This is a report of a possible correlation between Eskazole use and the following symptoms/side effect(s):
  • Alanine Aminotransferase Increased
  • Aspartate Aminotransferase Increased
  • Liver Disorder
which could contribute to an assessment of Eskazole risk profile.A 42-year-old female consumer from JAPAN (weight: NA) was suffering from toxocariasis and was treated with Eskazole (dosage: 200mg Three Times Per Day) starting Sep 06, 2008.Other concurrent medications: NA.

Bone Marrow Failure, Granulocytopenia, Leukopenia
A 61-year-old female patient from NETHERLANDS (weight: NA) presented with the following symptoms: echinococciasis and after a treatment with Eskazole (dosage: 400mg Twice Per Day) experienced the following side effect(s):
  • Bone Marrow Failure
  • Granulocytopenia
  • Leukopenia
The treatment was started on May 14, 2008. Eskazole was used in combination with the following drugs:
  • Alendronate Sodium (70mg Weekly)
  • Pantozol (40mg Per Day)
  • Acetaminophen (500mg Four Times Per Day)
  • Spironolactone (200mg Per Day)
  • Temazepam (10mg Per Day)
The patient was hospitalized.This report could alert potential Eskazole consumers.

Hepatic Enzyme Increased, Hepatitis
In this report, a 55-year-old male patient from FRANCE (weight: NA) was affected by a possible Eskazole side effect.The patient was diagnosed with NA. After a treatment with Eskazole (dosage: NA, start date: Dec 18, 2006), the patient experienced the following side effect(s):
  • Hepatic Enzyme Increased
  • Hepatitis
The following simultaneously used drugs could have led to this reaction:
  • Parkinane
  • Trivastal
  • Prozac
  • Selegiline Hcl
The findings here stress that side effects should be taken into consideration when evaluating a Eskazole treatment.

Endometrial Cancer, Gamma-glutamyltransferase Increased, Transaminases Increased
This is a report of a 72-year-old female patient from FRANCE (weight: NA), who used Eskazole (dosage: NA) for a treatment of NA. After starting a treatment on Mar 18, 2008, the patient experienced the following side effect(s):
  • Endometrial Cancer
  • Gamma-glutamyltransferase Increased
  • Transaminases Increased
The following drugs could possibly have interacted with the Eskazole treatment
  • Hyperium
  • Furosemide
  • Iskedyl
  • Advil Liqui-gels
  • Daflon
Taken together, these observations suggest that a Eskazole treatment could be related to side effect(s), such as Endometrial Cancer, Gamma-glutamyltransferase Increased, Transaminases Increased.

Asthenia, Gamma-glutamyltransferase Increased, Hepatitis, Transaminases Increased
This asthenia side effect was reported by a physician from FRANCE. A 73-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA. The patient was prescribed Eskazole (dosage: NA), which was started on Nov 26, 2007. Concurrently used drugs:
  • Irbesartan
  • Avandia
  • Pravastatin
When starting to take Eskazole the consumer reported the following symptoms:
  • Asthenia
  • Gamma-glutamyltransferase Increased
  • Hepatitis
  • Transaminases Increased
These side effects may potentially be related to Eskazole.

Histiocytosis Haematophagic
This is a Eskazole side effect report of a 87-year-old female patient (weight:NA) from JAPAN, suffering from the following symptoms/conditions: hepatic echinococciasis, who was treated with Eskazole (dosage:200mg Three Times Per Day, start time: NS), combined with: NA., and developed a serious reaction and a histiocytosis haematophagic side effect. The patient presented with:
  • Histiocytosis Haematophagic
which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Eskazole treatment in female patients suffering from hepatic echinococciasis, resulting in histiocytosis haematophagic.

Alopecia, Anaemia, Neutrophil Count Decreased
This report suggests a potential Eskazole alopecia side effect(s) that can have serious consequences. A 30-year-old male patient from JAPAN (weight:NA) was diagnosed with the following health condition(s): NA and used Eskazole (dosage: 200mg Three Times Per Day) starting NS. Soon after starting Eskazole the patient began experiencing various side effects, including:
  • Alopecia
  • Anaemia
  • Neutrophil Count Decreased
Drugs used concurrently:NA. The patient was hospitalized. Although Eskazole demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as alopecia, may still occur.

Neutrophil Count Decreased, Pneumonia, Sepsis
This neutrophil count decreased problem was reported by a physician from JAPAN. A 62-year-old male patient (weight: NA) was diagnosed with the following medical condition(s): hepatic echinococciasis.On NS a consumer started treatment with Eskazole (dosage: 200mg Three Times Per Day). The following drugs/medications were being taken at the same time: NA. When commencing Eskazole, the patient experienced the following unwanted symptoms /side effects:
  • Neutrophil Count Decreased
  • Pneumonia
  • Sepsis
The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as neutrophil count decreased, may become evident only after a product is in use by the general population.

Arrhythmia, Palpitations, Supraventricular Tachycardia, White Blood Cell Count Decreased
This is a Eskazole side effect report of a 70-year-old female patient (weight: NA) from JAPAN. The patient developed the following symptoms/conditions: hepatic echinococciasis,gastritis and was treated with Eskazole (dosage: 200mg Three Times Per Day) starting Feb 06, 2008. Concurrently used drugs:
  • Famotidine (20mg Twice Per Day)
  • Biofermin R (1g Twice Per Day)
  • Kaytwo (5mg Twice Per Day)
  • Spelear (200mg Twice Per Day)
  • Ferromia (50mg Per Day)
Soon after that, the consumer experienced the following of symptoms:
  • Arrhythmia
  • Palpitations
  • Supraventricular Tachycardia
  • White Blood Cell Count Decreased
The patient was hospitalized. This opens a possibility that Eskazole could cause arrhythmia and that some female patients may be more susceptible.

Abortion Missed, Excoriation
A 36-year-old female patient (weight: NA) from GERMANY with the following symptoms: infection parasitic started Eskazole treatment (dosage: 400mg Per Day) on Apr 28, 2008. Soon after starting Eskazole treatment, the consumer experienced several side effects, including:
  • Abortion Missed
  • Excoriation
. Concurrently used drugs: NA. This finding indicates that some patients can be more vulnerable to developing Eskazole side effects, such as abortion missed.

Arrhythmia, Cardiac Disorder, Palpitations, Supraventricular Tachycardia, White Blood Cell Count Decreased
This arrhythmia side effect was reported by a physician from JAPAN. A 70-year-old female patient (weight:NA) experienced the following symptoms/conditions: hepatic echinococciasis,gastritis,diarrhoea,haemorrhage prophylaxis,productive cough,anaemia.The patient was prescribed Eskazole (dosage: 200mg Three Times Per Day), which was started on Feb 06, 2008. Concurrently used drugs:
  • Gaster D (20mg Twice Per Day)
  • Biofermin R (1g Twice Per Day)
  • Kaytwo (5mg Twice Per Day)
  • Spelear (200mg Twice Per Day)
  • Ferrous Sulfate Tab (50mg Per Day)
.When starting to take Eskazole the consumer reported symptoms, such as:
  • Arrhythmia
  • Cardiac Disorder
  • Palpitations
  • Supraventricular Tachycardia
  • White Blood Cell Count Decreased
These side effects may potentially be related to Eskazole. The patient was hospitalized.

Arrhythmia, Palpitations, Tachycardia, White Blood Cell Count Decreased
This is a report of a 70-year-old female patient (weight: NA) from JAPAN, suffering from the following symptoms/conditions: hepatic echinococciasis,gastritis, who was treated with Eskazole (dosage: 200mg Three Times Per Day, start time: Feb 06, 2008), combined with:
  • Gaster D (20mg Twice Per Day)
  • Biofermin R (1g Twice Per Day)
  • Kaytwo (5mg Twice Per Day)
  • Spelear (200mg Twice Per Day)
  • Ferromia (50mg Per Day)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Arrhythmia
  • Palpitations
  • Tachycardia
  • White Blood Cell Count Decreased
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Eskazole treatment in female patients, resulting in arrhythmia side effect. The patient was hospitalized.

Alopecia, Pancytopenia, Red Blood Cell Count Decreased, White Blood Cell Count Decreased
This report suggests a potential Eskazole Alopecia, Pancytopenia, Red Blood Cell Count Decreased, White Blood Cell Count Decreased side effect(s) that can have serious consequences. A 73-year-old male patient (weight: NA) from JAPAN was diagnosed with the following symptoms/conditions: echinococciasis and used Eskazole (dosage: 200mg Three Times Per Day) starting Jan 24, 2008. Soon after starting Eskazole the patient began experiencing various side effects, including:
  • Alopecia
  • Pancytopenia
  • Red Blood Cell Count Decreased
  • White Blood Cell Count Decreased
Drugs used concurrently:
  • Glycyron
  • Urso 250 (300mg Per Day)
  • Gaslon N (4mg Per Day)
  • Harnal (.2mg Per Day)
The patient was hospitalized. Although Eskazole demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as alopecia, may still occur.

Aspartate Aminotransferase Increased, Hepatic Enzyme Increased, Hepatitis
This Aspartate Aminotransferase Increased, Hepatic Enzyme Increased, Hepatitis problem was reported by a physician from GERMANY. A 28-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: echinococciasis. On Nov 29, 2005 this consumer started treatment with Eskazole (dosage: 400mg Twice Per Day). The following drugs were being taken at the same time: NA. When commencing Eskazole, the patient experienced the following unwanted symptoms/side effects:
  • Aspartate Aminotransferase Increased
  • Hepatic Enzyme Increased
  • Hepatitis
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as aspartate aminotransferase increased, may become evident only after a product is in use by the general population.

Hepatitis Toxic
This is a report of a 30-year-old male patient (weight: NA) from FRANCE. The patient developed the following symptoms/conditions: hepatic echinococciasis and was treated with Eskazole (dosage: 200mg Four Times Per Day) starting Dec 06, 2005. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
  • Hepatitis Toxic
The patient was hospitalized. This opens a possibility that Eskazole treatment could cause the above reactions, including hepatitis toxic, and some male subjects may be more susceptible.

Hip Dysplasia, Osteoarthritis
A 36-year-old male patient (weight: NA) from GERMANY with the following symptoms/conditions: echinococciasis started Eskazole treatment (dosage: 400mg Twice Per Day) on Apr 19, 2002. Soon after starting Eskazole treatment, the subject experienced various side effects, including:
  • Hip Dysplasia
  • Osteoarthritis
Concurrently used drugs:
  • Diclac
This finding indicates that some male patients could be more vulnerable to Eskazole.

1 of 2 



Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Eskazole Side Effects

    Did You Have a Eskazole Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Eskazole for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Eskazole Safety Alerts, Active Ingredients, Usage Information

    More About Eskazole

    Side Effects reported to FDA: 32

    Eskazole safety alerts: No

    Reported deaths: 4

    Reported hospitalizations: 13

    Latest Eskazole clinical trials

    Eskazole Reviews

    No reviews, be a first to report a side effect via side effect reporting form